HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug.

Abstract
We have used structure-based design techniques to introduce the drug O(2)-[2,4-dinitro-5-(N-methyl-N-4-carboxyphenylamino) phenyl] 1-N,N-dimethylamino)diazen-1-ium-1,2-diolate (PABA/NO), which is efficiently metabolized to potentially cytolytic nitric oxide by the pi isoform of glutathione S-transferase, an enzyme expressed at high levels in many tumors. We have used mouse embryo fibroblasts (MEFs) null for GSTpi (GSTpi(-/-)) to show that the absence of GSTpi results in a decreased sensitivity to PABA/NO. Cytotoxicity of PABA/NO was also examined in a mouse skin fibroblast (NIH3T3) cell line that was stably transfected with GSTpi and/or various combinations of gamma-glutamyl cysteine synthetase and the ATP-binding cassette transporter MRP1. Overexpression of MRP1 conferred the most significant degree of resistance, and in vitro transport studies confirmed that a GSTpi-activated metabolite of PABA/NO was effluxed by MRP1 in a GSH-dependent manner. Additional studies showed that in the absence of MRP1, PABA/NO activated the extracellular-regulated and stress-activated protein kinases ERK, c-Jun NH(2)-terminal kinase (JNK), and p38. Selective inhibition studies showed that the activation of JNK and p38 were critical to the cytotoxic effects of PABA/NO. Finally, PABA/NO produced antitumor effects in a human ovarian cancer model grown in SCID mice.
AuthorsVictoria J Findlay, Danyelle M Townsend, Joseph E Saavedra, Gregory S Buzard, Michael L Citro, Larry K Keefer, Xinhua Ji, Kenneth D Tew
JournalMolecular pharmacology (Mol Pharmacol) Vol. 65 Issue 5 Pg. 1070-9 (May 2004) ISSN: 0026-895X [Print] United States
PMID15102935 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Azo Compounds
  • Isoenzymes
  • Multidrug Resistance-Associated Proteins
  • Nitric Oxide Donors
  • O(2)-(2,4-dinitro-5-(N-methyl-N-4-carboxyphenylamino)phenyl 1-N,N-dimethylamino)diazen-1-ium-1,2-diolate
  • O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate
  • Piperazines
  • Prodrugs
  • para-Aminobenzoates
  • Leukotriene C4
  • Nitric Oxide
  • Glutathione S-Transferase pi
  • Glutathione Transferase
  • Gstp1 protein, mouse
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • 4-Aminobenzoic Acid
Topics
  • 3T3 Cells
  • 4-Aminobenzoic Acid (chemical synthesis, chemistry, pharmacology)
  • Animals
  • Azo Compounds (chemical synthesis, chemistry, pharmacology)
  • Cell Division (drug effects)
  • Enzyme Activation (drug effects)
  • Glutathione S-Transferase pi
  • Glutathione Transferase (metabolism)
  • Isoenzymes (metabolism)
  • JNK Mitogen-Activated Protein Kinases
  • Leukotriene C4 (metabolism)
  • Mice
  • Mice, SCID
  • Mitogen-Activated Protein Kinases (metabolism)
  • Multidrug Resistance-Associated Proteins (metabolism)
  • Nitric Oxide (metabolism)
  • Nitric Oxide Donors (pharmacology)
  • Piperazines (pharmacology)
  • Prodrugs (pharmacology)
  • Tumor Cells, Cultured
  • p38 Mitogen-Activated Protein Kinases
  • para-Aminobenzoates

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: